BETA-ADRENERGIC BLOCKING-AGENTS AND ANTIHYPERTENSIVE ACTIVITY

被引：0
|
作者：
BRUNNER, H [1 ]
机构：
[1] CIBA GEIGY AG,CH-4002 BASEL,SWITZERLAND
来源：
ZEITSCHRIFT FUR KARDIOLOGIE | 1977年 / 66卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：518 / 518
页数：1
相关论文
共 50 条
  • [41] ANTAGONIZING ACTIVITY OF BETA-ADRENERGIC BLOCKING-AGENTS TO OUABAIN TOXICITY .2.
    SEKIYA, A
    YAMAMOTO, J
    MAEKAWA, H
    KATO, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1975, 25 : P181 - P181
  • [42] EFFECT OF BETA-ADRENERGIC BLOCKING-AGENTS TRIMEPRANOL AND PROPRANOLOL ON ERYTHROPOIESIS
    ZIVNY, J
    OSTADAL, B
    NEUWIRT, J
    PHYSIOLOGIA BOHEMOSLOVACA, 1980, 29 (05): : 479 - 480
  • [43] TREATMENT OF OCULAR HYPERTENSION WITH ORAL BETA-ADRENERGIC BLOCKING-AGENTS
    PANDOLFI, M
    OHRSTROM, A
    ACTA OPHTHALMOLOGICA, 1974, 52 (04): : 464 - 467
  • [44] BETA-ADRENERGIC BLOCKING-AGENTS IN PATIENTS WITH RENAL-FAILURE
    WARREN, DJ
    SWAINSON, CP
    WRIGHT, N
    BRITISH MEDICAL JOURNAL, 1974, 3 (5932): : 685 - 685
  • [45] EFFECT OF BETA-ADRENERGIC BLOCKING-AGENTS ON SPONTANEOUS MOTILITY OF MICE
    FABIAN, HEM
    IZQUIERD.JA
    ARZNEIMITTEL-FORSCHUNG, 1972, 22 (08): : 1375 - &
  • [46] INTRAMOLECULAR HYDROGEN-BONDING IN BETA-ADRENERGIC BLOCKING-AGENTS
    LAXER, M
    CAPOMACCHIA, AC
    HARDEE, GE
    TALANTA, 1981, 28 (12) : 973 - 976
  • [47] BETA-ADRENERGIC BLOCKING-AGENTS IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
    MINUTILLO, S
    LUPINC, V
    DAGNOLO, B
    MINERVA MEDICA, 1979, 70 (57) : 3919 - 3924
  • [48] ELEVATION OF VENTRICULAR FIBRILLATORY THRESHOLD BY BETA-ADRENERGIC BLOCKING-AGENTS
    BAUM, T
    PETERS, JR
    ECKFELD, DK
    VARNER, LL
    DINISH, J
    METZ, N
    SHROPSHIRE, AT
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1972, 200 (02): : 292 - 300
  • [49] BETA-ADRENERGIC BLOCKING-AGENTS FOR EXERTIONAL ANGINA-PECTORIS
    THADANI, U
    HERZ, 1982, 7 (03) : 179 - 187
  • [50] BETA-ADRENERGIC BLOCKING-AGENTS FOR ANTIPSYCHOTIC-INDUCED AKATHISIA
    DOLE, E
    WELLS, BG
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (7-8): : 618 - 619
12345